| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/06/1992 | CA2054659A1 Dynemicin c antitumour antibiotic |
| 05/05/1992 | US5110921 7-acylamino-3-vinylcephalosporanic acid derivatives |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110811 Antibody inhibitors |
| 05/05/1992 | US5110799 Inhibition of viral ribonucleotide reductase |
| 05/05/1992 | US5110798 Purine derivatives having pharmacological action |
| 05/05/1992 | US5110589 Antigen from surface of Treponema hyodysenteriae |
| 05/05/1992 | CA1300135C Substituted quinoxalines |
| 05/05/1992 | CA1300131C Antibiotics retinoid esters, their preparation process and pharmaceutical and cosmetical compositions containing them |
| 05/05/1992 | CA1300059C Antibiotic vermisporin, process for the production thereof and pharmaceutical composition comprising it as an active antibacterial agent |
| 05/02/1992 | WO1992007866A1 Anthracycline analogues bearing latent alkylating substituents |
| 05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
| 05/01/1992 | WO1992007856A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES |
| 05/01/1992 | CA2095219A1 Substituted indolizino[1,2-b]quinolinones |
| 05/01/1992 | CA2052246A1 Lithium treatment |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | WO1992007065A1 Modified ribozymes |
| 04/30/1992 | WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | WO1992006978A1 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
| 04/30/1992 | WO1992006695A1 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 04/30/1992 | WO1992006677A1 Artificial viral envelopes |
| 04/30/1992 | WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs |
| 04/30/1992 | WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes |
| 04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
| 04/29/1992 | EP0483070A2 Nutritionally complete feeding composition containing hydrolysed soluble fiber |
| 04/29/1992 | EP0482797A1 Inhibitors of HIV protease |
| 04/29/1992 | EP0482594A1 Tylosin derivative and method for preparing the same |
| 04/29/1992 | EP0482543A1 Oasomycine, method of its preparation and its use |
| 04/29/1992 | EP0482481A1 Method for the preparation of 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482071A1 New antiviral agents |
| 04/29/1992 | EP0481994A1 Metallo-organic cobalt compounds and uses thereof |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5108997 Cephem compounds |
| 04/28/1992 | US5108994 Antiviral purine derivatives |
| 04/28/1992 | US5108993 Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids-related syndromes |
| 04/28/1992 | US5108988 Hydrogenated derivatives of antibiotic a/16686 |
| 04/28/1992 | US5108747 Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors |
| 04/28/1992 | US5108745 Tuberculosis and legionellosis vaccines and methods for their production |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299567C Esperamicin derivatives |
| 04/28/1992 | CA1299565C Penem compounds, production and use thereof |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2054232A1 Oasomycins, a process for the preparation thereof and the use thereof |
| 04/26/1992 | WO1992007873A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | WO1992007582A1 Corynebacteria and related organisms as vaccine vectors |
| 04/26/1992 | CA2094718A1 Corynebacteria and related organisms as vaccine vectors |
| 04/26/1992 | CA2091760A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | CA2053800A1 Tylosin derivative and method for preparing the same |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | WO1992006693A1 Dna construct for providing rna therapy |
| 04/23/1992 | CA2094608A1 Dna construct for providing rna therapy |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | CA2053159A1 Antibiotic c-3 cyclobutenedione substituted (1-carba) cephalosporin compounds, compositions, and methods of use thereof |
| 04/22/1992 | EP0481802A1 Hydroxylated inhibitors of HIV reverse transcriptase |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481754A2 Hydroxymethyl(methylenecyclopentyl)Purines and Pyrimidines |
| 04/22/1992 | EP0481701A1 Treatment composition |
| 04/22/1992 | EP0481662A1 2-Heteroarylphenyl-carbapenem antibacterial agents |
| 04/22/1992 | EP0481511A2 Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and use thereof |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | EP0481274A1 7-(2,7-Diazabicyclo[3.3.0]octyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives |
| 04/22/1992 | EP0481214A1 Prodrugs of phosphonates |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0471683A4 Bis-(pyrrolidonyl alkylene) biguanides |
| 04/22/1992 | CN1060473A Fungicidally active compounds |
| 04/22/1992 | CN1060469A Process for preparing cephalosporins derivants |
| 04/22/1992 | CN1016315B Process for preparing hepatitis b antigenic compositions |
| 04/21/1992 | US5106962 Reacting nucleosides with viologens in the presence of base |
| 04/21/1992 | US5106961 Erythromycin ring-contracted derivatives |
| 04/21/1992 | US5106878 Use of substituted aminoalkoxybenzene derivatives in the control or prevention of fungal infections |
| 04/21/1992 | US5106866 Skin disorders |
| 04/21/1992 | US5106854 Bactericides |
| 04/21/1992 | US5106842 Antibiotic c-3 cyclobutenedione substituted (1-carba)cephalosporin compounds, compositions, and methods of use thereof |
| 04/21/1992 | US5106841 Antiviral compositions and method for their use |
| 04/21/1992 | US5106840 Method of preparing n-oxo-tetrahydro-beta-carbolines |
| 04/21/1992 | CA1299176C Process for preparing isoxazole and furan derivatives |
| 04/21/1992 | CA1299171C Tricyclic cepham compounds, their production and use |
| 04/21/1992 | CA1299121C Infectious bovine rhinotracheitis virus mutants, vaccines containingsame, methods for the production of same and methods for the use of same |
| 04/21/1992 | CA1299098C Alcohol-based antimicrobial compositions |
| 04/20/1992 | CA2052946A1 Method for the preparation of 5,11-dihydro-6h-dipyrido ¬3,2-b:2', 3'-e| ¬1,4|diazepines |
| 04/20/1992 | CA2052942A1 Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/19/1992 | CA2053512A1 Hydroxylated inhibitors of hiv reverse transcriptase |
| 04/16/1992 | WO1992006106A1 A plant protein useful for treating tumors and hiv infection |
| 04/16/1992 | WO1992005803A1 Self-assembling ion pair drugs |
| 04/16/1992 | WO1992005800A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/16/1992 | WO1992005798A1 Acellular vaccine |
| 04/16/1992 | CA2093800A1 Plant protein useful for treating tumors and hiv infection |
| 04/16/1992 | CA2052971A1 2-heteroarylphenyl-carbapenem antibacterial agents |
| 04/15/1992 | EP0480901A1 Azido-substituted fatty acid analog enzyme substrates |
| 04/15/1992 | EP0480715A1 Intermediates for preparing 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents |
| 04/15/1992 | EP0480714A2 HIV protease inhibitors having symmetrical structure |